Table 2.

Characteristics of COVID-19 patients who received influenza and pneumococcal vaccination.

Variable	Category	N	%
Influenza (N = 240)
Age	≥ 65	201	83.75
Timing of influenza vaccination	October–November 2019	200	83.33
	December 2019–February 2020	40	16.67
Composition of influenza vaccine 2019	Trivalent	129	53.75
	Quadrivalent	111	46.25
Number of influenza vaccine uptake	Only 2019	54	22.50
	2 years (2018–2019)	0	0.00
	3 years (2017–2019)	46	19.17
	4 years (2016–2019)	22	9.17
	5 years (2015–2019)	118	49.17
Pneumococcal (N = 81)
Age	≥ 65	73	90.12
Type of vaccine	PCV13, Prevenar	81	100